NLRP3 inflammasome plays dual, time-dependent roles during acute wound healing

Wound healing is a multistep biological process involving inflammation, tissue formation, and remodeling. While inflammation is essential for clearing debris and recruiting repair cells, excessive or prolonged inflammatory responses can delay closure, increase fibrosis, and compromise tissue quality. The NLRP3 inflammasome is a central regulator of innate immunity and has been implicated in chronic wounds and pathological scarring. However, previous studies have reported conflicting roles for NLRP3 in tissue repair, suggesting that its effects depend on timing and cellular context. Based on these challenges, it is necessary to investigate how NLRP3 regulates wound healing in a spatiotemporal and phase-specific manner.

Researchers from the Chinese PLA General Hospital report that the NLRP3 inflammasome plays dual, time-dependent roles during acute wound healing, according to a study published (DOI: 10.1093/burnst/tkag002) in Burns & Trauma in January 2026. Using mouse and human wound models combined with multi-omics and single-cell analyses, the team demonstrates that NLRP3-driven inflammation is essential in early repair but becomes detrimental if sustained. Temporally modulating NLRP3 activity improved tissue regeneration, reduced scarring, and enhanced healing quality.

By integrating transcriptomics, single-cell RNA sequencing, and functional experiments, the researchers mapped dynamic changes in NLRP3 activity throughout wound healing. During the early inflammatory phase, NLRP3 was highly expressed in macrophages and neutrophils, where it promoted chemokine production and immune cell recruitment. These signals facilitated macrophage and fibroblast migration to the wound site and supported pro-inflammatory macrophage polarization, accelerating early wound closure.

Genetic deletion of Nlrp3, however, revealed a complex trade-off. Although early wound closure was delayed, later-stage healing was markedly improved. Nlrp3-deficient wounds showed reduced fibrosis, lower collagen overaccumulation, and enhanced regeneration of hair follicles and nerves. Mechanistically, reduced inflammatory signaling allowed earlier activation of regenerative pathways such as Wnt and Notch.

The study also uncovered an inflammasome-independent role for NLRP3 in fibroblasts. Beyond cytokine signaling, NLRP3 associated with mitochondria to regulate reactive oxygen species production, thereby modulating TGF-β/Smad signaling and fibroblast phenotype. Together, these findings position NLRP3 as a molecular switch that links inflammation intensity to repair quality.

"Inflammation is not simply beneficial or harmful—it has a timetable," said one of the senior investigators. "Our results show that NLRP3 activity is required early to initiate repair, but later needs to be restrained to prevent excessive scarring and allow proper regeneration." The researchers noted that this timing-dependent mechanism helps explain why broad anti-inflammatory treatments often fail in wound care. Instead, controlling when and where inflammatory pathways are activated may be the key to improving healing outcomes.

These findings offer important insights for treating acute and chronic wounds, including diabetic ulcers, surgical injuries, and burns. Rather than suppressing inflammation indiscriminately, future therapies could aim to fine-tune NLRP3 activity in a phase-specific manner—enhancing its function during early inflammation while limiting its effects during later repair. Such strategies may accelerate closure while reducing fibrosis and improving tissue regeneration. More broadly, this work provides a framework for understanding how temporally controlled immune responses shape tissue repair, with implications extending beyond skin wounds to other inflammation-driven regenerative processes.